Filing Details
- Accession Number:
- 0000899243-20-018041
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-06-30 20:07:40
- Reporting Period:
- 2020-06-26
- Accepted Time:
- 2020-06-30 20:07:40
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1419041 | Forte Biosciences Inc. | FBRX | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1339375 | A Antony Riley | C/O Forte Biosciences, Inc. 1124 W. Carson Street, Mrl Bldg. 3-320 Torrance CA 90502 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2020-06-26 | 4,700 | $14.52 | 34,065 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2020-06-29 | 2,000 | $14.11 | 36,065 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (right to buy) | Acquisiton | 2020-06-30 | 75,000 | $0.00 | 75,000 | $14.58 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
75,000 | 2030-06-30 | No | 4 | A | Direct |
Footnotes
- Represents the weighted average share price of an aggregate total of 4,700 shares purchased in the price range of $14.25 to $14.75 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
- Subject to the Reporting Person continuing to be a Service Provider (as defined in the 2017 Equity Incentive Plan) through each applicable vesting date, twenty five percent (25%) of the shares subject to the option shall vest on the one year anniversary of the Vesting Commencement Date and one forty-eighth (1/48th) of the total shares subject to the option shall vest every month thereafter such that all shares shall be fully vested on the four year anniversary of the Vesting Commencement Date. "Vesting Commencement Date" shall mean March 23, 2020.